Pediatric Oncology 1: with a special section on Rare Primitive Neuroectodermal Tumors: Cancer Treatment and Research, cartea 2
Editat de G. Bennett Humphrey, Louis P. Dehner, Gerald B. Grindey, Ronald T. Actonen Limba Engleză Paperback – 6 noi 2011
Din seria Cancer Treatment and Research
- 14% Preț: 978.30 lei
- 14% Preț: 644.22 lei
- 5% Preț: 771.65 lei
- 5% Preț: 1016.90 lei
- 5% Preț: 1011.74 lei
- 5% Preț: 1020.65 lei
- 5% Preț: 898.85 lei
- 5% Preț: 704.49 lei
- 5% Preț: 901.54 lei
- 5% Preț: 472.89 lei
- 5% Preț: 651.81 lei
- 5% Preț: 491.33 lei
- 5% Preț: 706.62 lei
- 5% Preț: 362.94 lei
- 15% Preț: 685.93 lei
- 5% Preț: 2073.87 lei
- 5% Preț: 1385.39 lei
- 5% Preț: 1395.26 lei
- 5% Preț: 1084.27 lei
- 5% Preț: 1271.32 lei
- 5% Preț: 1080.88 lei
- 5% Preț: 1072.26 lei
- 5% Preț: 1074.24 lei
- 5% Preț: 1384.89 lei
- 5% Preț: 705.54 lei
- 5% Preț: 692.48 lei
- 5% Preț: 716.29 lei
- 5% Preț: 1386.09 lei
- 5% Preț: 1086.24 lei
- 5% Preț: 1075.86 lei
- 5% Preț: 1070.10 lei
- 5% Preț: 1077.27 lei
- 5% Preț: 1083.90 lei
Preț: 362.42 lei
Preț vechi: 381.50 lei
-5% Nou
Puncte Express: 544
Preț estimativ în valută:
69.35€ • 73.13$ • 57.74£
69.35€ • 73.13$ • 57.74£
Carte tipărită la comandă
Livrare economică 11-25 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789400982215
ISBN-10: 9400982216
Pagini: 316
Ilustrații: 312 p.
Dimensiuni: 155 x 235 x 17 mm
Greutate: 0.45 kg
Ediția:Softcover reprint of the original 1st ed. 1981
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Cancer Treatment and Research
Locul publicării:Dordrecht, Netherlands
ISBN-10: 9400982216
Pagini: 316
Ilustrații: 312 p.
Dimensiuni: 155 x 235 x 17 mm
Greutate: 0.45 kg
Ediția:Softcover reprint of the original 1st ed. 1981
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Cancer Treatment and Research
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
I. Selected Topics.- 1. Abnormal immunoregulation in pediatric cancer and immunodeficiency.- 2. The potential use of HLA to predict risk of malignant diseases and outcome of therapy.- 3. Interferon and cancer.- 4. Tumor heterogeneity.- 5. Biological markers of the tumors of the central nervous system.- 6. Non-chemotherapeutic approaches to uncontrolled CNS tumors.- 7. Advantages and disadvantages of adjuvant chemotherapy in the treatment of primary CNS tumors.- II. Rare Tumors of the Central Nervous System.- 8. Primitive neuroectodermal tumors of brain in childhood: literature review and the M.D. Anderson experience.- 9. Primary cerebral neuroblastomas.- 10. Cerebral primitive neuroectodermal tumor (primary cerebral neuroblastoma): CHLA experience.- 11. Supratentorial primitive neuroectodermal tumor: clinical response of a single case to vincristine, cyclophosphamide, and BCNU..- 12. Review of experience with primitive neuroectodermal tumors of childhood.- 13. Primitive neuroectodermal tumour.- 14. Primitive neuroectodermal tumors (embryonal gliomas) of child hood. A clinicopathologic study of 12 cases.- 15. Primitive neuroectodermal tumors of infancy and childhood.- 16. Poorly differentiated small cell tumours of the central nervous system that are not medulloblastomas.- 17. Primitive neuroectodermal tumors of the central nervous system in childhood. Retrospective and overview.- 18. Overview on the management of primitive neuroectodermal tumors.